QualityStocksNewsBreaks Archives - Page 577 of 1423

WednesdaySep 08, 2021 1:54 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Collaborates to Launch Cutting-Edge Global Cannabis Product Validation, Authentication Platform

Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its entry into agreements with TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF) and Applied DNA Sciences Inc. (NASDAQ: APDN) to launch a complete and differentiated global cannabis product validation and authentication platform for consumers, distributors and government regulators. The initiative further demonstrates Flora’s commitment to operational excellence and transparency enabling immutable genome-to-sale supply chain validation for domestic and international trading partners and government regulators. “In today’s globalized market, supply chain provenance is becoming an increasingly important component for every major international…

WednesdaySep 08, 2021 1:43 pm

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Secures USPTO Notice of Allowance for 3D-Beam Modulation Filter Patent

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, today announced its receipt of a Notice of Allowance in response to a patent application from the United States Patent and Trademark Office (“USPTO”). According to the update, the patent pertains to a specialized 3D x-ray filter, known as a 3D-Beam Modulation Filter, designed to tailor the shape of the IzoView x-ray beam to match the shape of the patient's breast being scanned. The filter provides patient and output benefits by…

WednesdaySep 08, 2021 1:34 pm

QualityStocksNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Appoints Robin Mackie as President of Its Mobility Division

Ideanomics (NASDAQ: IDEX), a global company focused on driving the adoption of commercial electric vehicles and associated energy consumption, today announced its appointment of Robin Mackie as president of Ideanomics Mobility — a division of the company that facilitates the adoption of electric vehicles by commercial fleet operators across vehicles, charging and energy. Prior to his appointment as president, Mackie served as a consultant for Ideanomics Mobility for six months. He brings over 30 years of experience in global design, engineering and operations in various highly regulated industries such as construction, offshore and automotive. “Robin has proven to be a…

WednesdaySep 08, 2021 12:29 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins IND-Enabling Program for DehydraTECH-CBD for Hypertension

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced it is formally beginning the process towards an Investigational New Drug (“IND”) application filing with the Food and Drug Administration (“FDA”). The IND filing is for Lexaria’s DehydraTECH-processed cannabidiol (“DehydraTECH-CBD”) as a prospective registered pharmaceutical treatment for hypertension. The company has retained the services of an expert regulatory affairs and quality assurance consultancy group to assist in preparing Lexaria for a pre-IND meeting with the FDA, as well as with designing the necessary non-clinical, clinical and related product development IND-enabling work to be completed in…

WednesdaySep 08, 2021 10:46 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Slated for Live Webcast at VirtualInvestorConferences.com

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), will be featured at the upcoming VirtualInvestorConferences.com. InMed president and CEO is scheduled to present a real-time, interactive presentations during the two-day conference; InMed’s presentation will start at 1:30 p.m. ET on Sept. 8, 2021. During the presentation Adams will provide an overview of the company’s recent highlights as well as answer questions from potential investors in real time. Company highlights include the announcement that it has increased the yield of its proprietary IntegraSyn(TM) rare…

WednesdaySep 08, 2021 10:36 am

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) to Participate in H.C. Wainwright Global Investment Conference

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF), a leader in advanced proprietary technology and research for psychedelics, has announced that it will featured at the upcoming H.C. Wainwright 23rd annual Global Investment Conference. The three-day conference is scheduled to begin Sept. 13 and runs through Sept. 15, 2021. MINDCURE president and CEO Kelsey Ramsden will present an overview of the company on Sept. 13, 2021, at 7 a.m. ET. The presentation will be available for interested viewers for 90 days following the conference. To view the presentation, visit https://ibn.fm/whfnm To view the full press release, visit https://ibn.fm/gmkso About Mind Cure Health…

WednesdaySep 08, 2021 9:00 am

QualityStocksNewsBreaks – Creative Medical Technology Holdings Inc. (CELZ) Secures $3.8M in Private Placement

Creative Medical Technology Holdings (OTC: CELZ) entered into definitive agreements with accredited institutional investors for gross proceeds of approximately $3,788,000. The definitive agreements provide for the private placement of 15% original issue discount senior notes (“notes”) in the aggregate principal amount of approximately $4,456,000; the principal amount of the notes will be due on Feb. 11, 2022. The company has also agreed to issue to the investors unregistered warrants for the purchase of 157,184,354 shares of common stock. Each warrant entitles the holder to purchase one share of common stock at an initial exercise price of $0.02835 for a period…

TuesdaySep 07, 2021 2:58 pm

QualityStocksNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Sequire Showcases Companies ‘Paving the Way for a Crypto Future’

SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. SRAX has upgraded the user experience on Sequire to add a new Investment Advisor feature and on-demand presentation replays from the 2021 Sequire Blockchain Conference. The event, hosted on SRAX’s investor analytics platform, was a huge success. “This conference was one of the best we’ve ever put on,” said SRAX CEO and Founder Christopher Miglino. “The content was educational, and the companies that presented are paving the way for a crypto future. If you have not already…

TuesdaySep 07, 2021 2:45 pm

QualityStocksNewsBreaks – Perpetual Industries Inc. (PRPI) Researching New, Revolutionary Design for Crypto-Mining Farm System

As China is cracking down on cryptocurrency mining over concerns about environmental impact, savvy U.S. companies, including Perpetual Industries (OTC: PRPI), are looking to benefit. A recent Forbes publication highlights this opportunity, reporting that mining is about to get both easier and more profitable for North American crypto miners (https://ibn.fm/2Li5e). Amid this backdrop, Perpetual Industries has been working to build an efficient, powerful network of cryptocurrency mining operations that offer environmentally friendly solutions for the sustainability of the blockchain industry (https://ibn.fm/sKkGH). “Our goal is to advance and integrate green energy power sources such as solar, wind and hydro in order…

TuesdaySep 07, 2021 2:34 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Positioned as First Mover in Psychedelics Space

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) CEO Greg McKee was recently hosted by Oren Klaff on the Dealmaker Podcast. The interview, which illuminated Tryp Therapeutics’ operations and McKee’s personal story on how he ended up as the CEO, offered some great insights into the future of the psychedelics space, along with what ordinary people can do to take the industry to the next level. A recent article reads, “Mr. McKee cited the benefits that come with the use of psilocybin in treating pain. For one, he discussed their effectiveness without the accompanying risk of addiction associated with opioids. He also…

Site Search

Company Search

Category: QualityStocksNewsBreaks